These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 13205794)

  • 41. Clinical experience with phenylindanedione (danilone) with special reference to dosage.
    BEAMISH RE; CARTER SA
    Can Med Assoc J; 1956 Jan; 74(1):39-42. PubMed ID: 13276902
    [No Abstract]   [Full Text] [Related]  

  • 42. The assay of phenylindanedione.
    SHARP LK
    J Pharm Pharmacol; 1955 Mar; 7(3):177-82. PubMed ID: 14354613
    [No Abstract]   [Full Text] [Related]  

  • 43. Long term treatment with anticoagulants in coronary artery disease.
    OWREN PA
    Thromb Diath Haemorrh; 1958 Nov; 2(5-6):492-504. PubMed ID: 13635665
    [No Abstract]   [Full Text] [Related]  

  • 44. [Thrombosis and cancer].
    Salama P
    An Sist Sanit Navar; 2004; 27 Suppl 3():45-51. PubMed ID: 15723104
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Venous thromboembolic disease in adolescents].
    Periard D; Haesler E; Ducrey N; von der Weid N; Mazzolai L
    Rev Med Suisse; 2006 Feb; 2(51):318-22. PubMed ID: 16512002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The physiologic disposition of phenylindanedione in man.
    SCHULERT AR; WEINER M
    J Pharmacol Exp Ther; 1954 Apr; 110(4):451-7. PubMed ID: 13163837
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hemorrhagic cutaneous necrosis in phenylindanedione].
    KEYRILAINEN O
    Nord Med; 1958 Apr; 59(16):567. PubMed ID: 13553055
    [No Abstract]   [Full Text] [Related]  

  • 48. Distribution of phenylindanedione in blood and tissues after oral and intravenous administration.
    MILLAR GJ; MERSEREAU MO; LOWENTHAL J; JAQUES LB
    Thromb Diath Haemorrh; 1958 Sep; 2(3-4):236-49. PubMed ID: 13592809
    [No Abstract]   [Full Text] [Related]  

  • 49. Fibrinolytic enzymes in thromboembolic disorders.
    CLIFFTON EE
    Semin Rep Merck Sharp Dohme; 1960; 5():2-9. PubMed ID: 13694111
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of thromboembolic diseases by sintrom (G-23350)].
    CARRILLO P; TOLEDO FB; MILANES B; PEREZ M
    Angiologia; 1958; 10(4):230-8. PubMed ID: 13545604
    [No Abstract]   [Full Text] [Related]  

  • 51. Sensitivity to dindevan (phenylindanedione) report of a case with review of the literature.
    BURNS C; DESMOND FB
    N Z Med J; 1958 Jun; 57(319):283-91. PubMed ID: 13566567
    [No Abstract]   [Full Text] [Related]  

  • 52. [Problems regarding anticoagulant treatment of various thromboembolic diseases; casuistic contribution].
    CROLLE G; BIANCO S; BUCHI G
    Minerva Med; 1959 Feb; 50(11):324-33. PubMed ID: 13643848
    [No Abstract]   [Full Text] [Related]  

  • 53. [Agranulocytosis occurring during treatment with phenylindanedione].
    Malinvaud G; de Leobardy J; Suchaud C
    Presse Med (1893); 1966 Aug; 74(36):1845-8. PubMed ID: 5958086
    [No Abstract]   [Full Text] [Related]  

  • 54. [Examinations of coagulation in the anticoagulant treatment of thromboembolic diseases].
    GUASCH J
    Angiologia; 1961; 13():175-80. PubMed ID: 13709347
    [No Abstract]   [Full Text] [Related]  

  • 55. [Fibrinolytic therapy and anticoagulation prophylaxis in thromboembolic diseases].
    MENEGHINI P
    Minerva Med; 1955 Feb; 46(13):393-402. PubMed ID: 14355901
    [No Abstract]   [Full Text] [Related]  

  • 56. [Thromboelastographic research on local drug prevention & therapy of thromboembolic diseases].
    BENZER H
    Klin Med Osterr Z Wiss Prakt Med; 1958 Jun; 13(6):233-41. PubMed ID: 13576721
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of inferior vena cava filters in thromboembolic disease during labor: case report with a literature review.
    Jamjute P; Reed N; Hinwood D
    J Matern Fetal Neonatal Med; 2006 Nov; 19(11):741-4. PubMed ID: 17127498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications.
    Twig G; Zandman-Goddard G; Szyper-Kravitz M; Shoenfeld Y
    Ann N Y Acad Sci; 2005 Jun; 1051():166-73. PubMed ID: 16126956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effect of 2-phenyl-1-3-diketohydrindene on blood coagulation].
    SCHMID J; VINAZZER H
    Wien Z Inn Med; 1953 May; 34(5):194-9. PubMed ID: 13090767
    [No Abstract]   [Full Text] [Related]  

  • 60. [Recently introduced anticoagulants].
    HILDEN T; MUNCK O
    Ugeskr Laeger; 1954 Feb; 116(8):286-8. PubMed ID: 13146903
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.